Search company, investor...

Predict your next investment

Venture Capital

Investments

10

Funds

1

About Hambrecht Ducera Growth Ventures

HDGV is a venture capital firm led by Bill Hambrecht, Mike Kramer and Thomas Thurston that uses data science to identify early-stage disruptive growth companies.

Headquarters Location

499 Park Avenue Suite 1600

New York, New York, 10022,

United States

212-671-9734

Want to inform investors similar to Hambrecht Ducera Growth Ventures about your company?

Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.

Latest Hambrecht Ducera Growth Ventures News

Tasso Announces $100M Series B Round

Dec 16, 2021

Tasso, a leader in clinical-grade blood collection technology, today announced that it has completed an oversubscribed $100 million Series B financing round, bringing the total funding to date to $131 million. The financing round was led by RA Capital Management and included participation from new investors the D.E. Shaw group, Senvest, InCube, and SVB Innovation Fund, as well as existing investors Foresite Capital, Hambrecht Ducera Growth Ventures, J2V, Cedars-Sinai, and Merck GHIF. Tasso is an emerging healthcare technology company that is transforming the traditional blood collection paradigm with a patient-centric approach. The company's devices enable simple, convenient, and virtually painless blood collection for users. Tasso technology has the power to bring healthcare anywhere, any time. (c)2011-2020 by Massinvestor, Inc. For contact info, please check out our about page.

Hambrecht Ducera Growth Ventures Investments

10 Investments

Hambrecht Ducera Growth Ventures has made 10 investments. Their latest investment was in Tasso as part of their Series B on December 12, 2021.

CBI Logo

Hambrecht Ducera Growth Ventures Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

12/16/2021

Series B

Tasso

$100M

No

19

7/7/2021

Series A

Proov

$9.7M

Yes

3

2/9/2021

Growth Equity

PatientsLikeMe

$26M

Yes

6

11/10/2020

Series C

Subscribe to see more

$99M

Subscribe to see more

10

8/19/2020

Series A - II

Subscribe to see more

$99M

Subscribe to see more

10

Date

12/16/2021

7/7/2021

2/9/2021

11/10/2020

8/19/2020

Round

Series B

Series A

Growth Equity

Series C

Series A - II

Company

Tasso

Proov

PatientsLikeMe

Subscribe to see more

Subscribe to see more

Amount

$100M

$9.7M

$26M

$99M

$99M

New?

No

Yes

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

19

3

6

10

10

Hambrecht Ducera Growth Ventures Fund History

1 Fund History

Hambrecht Ducera Growth Ventures has 1 fund, including Hambrecht Ducera Healthcare Growth Venture Fund I.

Closing Date

Fund

Fund Type

Status

Amount

Sources

1/9/2019

Hambrecht Ducera Healthcare Growth Venture Fund I

$25M

1

Closing Date

1/9/2019

Fund

Hambrecht Ducera Healthcare Growth Venture Fund I

Fund Type

Status

Amount

$25M

Sources

1

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Join a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.